Morgan Stanley highlights high-risk, high-reward biotech stocks poised for massive upside following key upcoming clinical ...
Investor's Business Daily on MSN
The biggest losers in biotech — and it had nothing to do with 'compelling,' 'best-in-disease' data
Biotech stocks widely slumped Wednesday, with Rapport Therapeutics, Climb Bio and Cullinan Therapeutics among some of the ...
Immunovant shares were on track for their worst session in over a year after the biotech said it was halting development of ...
VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund ...
Eli Lilly-backed TRex Bio and hypertension-focused Retension Pharmaceuticals are the latest biotechs to set out plans to go ...
Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced ...
The United States was a global manufacturing powerhouse. From the end of World War II into the 1970s, we were a dominant force in industrial production and manufacturing innovation. Since the late ...
Meroueh may have found a way to clean up steelmaking without driving up the price. Her new furnace turns iron ore into ...
Trade Brains on MSN
Concord Biotech approves 1:1 bonus issue; authorised capital raised to Rs22 crore
India, Sept. 24 -- This company is a pharmaceutical company whose activities include the production and development of fermentation derived APIs and dosage forms. This company has an involvement in ...
AJ Scaramucci's Solari Capital exits stealth with $350M deployed across AI, biotech, Bitcoin mining, and DeFi under a programmable reality ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results